Skip to main content
LIN logo

LIN · Linde PLC

Track LIN — free
$524.74 +13.19 (+2.58%) At close · Nov 4
Market Cap
$234.84B
Shares
459.08M
Volume · Nov 4 2.33M Avg daily vol (3M) 2.05M

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$524.74 Open$520.31 Day$513.02–526.56 52W close$389.38–546.64 Avg vol 30d2.1M Short int6.2M · 1.3% of shares · 2.9d Short vol51% Last earningsOct 29, 2026 DataJan 2020–Nov 2026 Filing10-Q · Oct 29

Up next

Jan 28, 2027 Est · unconfirmed · in 12 wks

Latest documents

2026
Oct 29
Earnings call
Q3 2026 earnings call

Linde recorded third-quarter sales of $9.4 billion and EPS of $4.59, took a $425 million restructuring charge, and guided fourth-quarter EPS to $4.40 to $4.50 and full-year EPS to $17.82 to $17.92.

Oct 29
Quarterly report 10-Q FY2026 Q3, ended Sep 30
Quarterly report for FY2026 Q3

Linde's third-quarter 2026 sales were $9,404 million, up 9%; adjusted operating profit rose 8% to $2,763 million and adjusted EPS rose 9% to $4.59. Nine-month operating cash flow was $7,680 million, capital expenditures $4,172 million, and backlog approximately $7.9 billion.

Revenue $9.4B ▲ 9.2% Net income $1.69B ▼ 12.3% Diluted EPS $3.66 ▼ 10.5%
Read from the MD&A section
Oct 29
Current report 8-K
Third-quarter sales rise 9%, adjusted EPS advances 9%

Linde plc reported third-quarter 2026 sales of $9.4 billion, up 9%, and adjusted EPS of $4.59, up 9%. Full-year adjusted EPS guidance is $17.82 - $17.92, up 8% to 9%, while operating cash flow reached $3.2 billion.

Financial results
5 source passages
Linde plc (Nasdaq: LIN) today reported third-quarter 2026 net income of $1,692 million and diluted earnings per share of $3.66, down 12% and 11%, respectively. Sales $9.4 billion, up 9% YoY, underlying sales up 5% EPS $3.66, down 11%; adjusted EPS $4.59, up 9% YoY Full-year 2026 adjusted EPS guidance of $17.82 - $17.92 representing 8% to 9% growth Third-quarter operating cash flow of $3.2 billion, up 8% YoY Open the document at this passage
Jul 31
Quarterly report 10-Q FY2026 Q2, ended Jun 30
Quarterly report for FY2026 Q2 AI summary on its way
Revenue $9.29B ▲ 9.3% Net income $1.93B ▲ 9.2% Diluted EPS $4.15 ▲ 11.3%
All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$36.24B
Trailing 12 months
Net income (TTM)
$7.01B
Trailing 12 months
Revenue growth YoY
+9.2%
Year over year
Operating margin
25.3%
Trailing 12 months
P / E (TTM)
33.9
Trailing earnings · reciprocal yield 2.9%
FCF yield
2.2%
TTM · current market cap
Return on invested capital
12.2%
Trailing 12 months
Net cash
−$18.11B
Latest balance sheet
Dividend yield
1.2%
Trailing 12 months
Shares change YoY
-1.9%
Year over year · fewer shares
Price change (1Y)
+24.1%
Trailing year
Short interest
1.3%
Latest settlement · 2.9 days to cover
View all 122 metrics

Equibles Rating

blended score · not investment advice
Overall
Buy
SellHoldBuy
Technical Strong Buy Momentum Very Strong Sentiment Neutral Fundamentals Strong Quant / Vol Very Low
Market backdrop VIX 16.6 · calm Equity put/call 0.44
Technical
price trend
Strong Buy
50 / 200-day cross No cross
Price vs 200-day avg +6%
above
Price vs 50-day avg +8%
above
RSI (14) 70
neutral
MACD trend Positive
52-week position 86%
near high
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Strong
1-month return +8%
trailing
6-month return +3%
trailing
YTD return +23%
this year
Relative strength 0%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $485 › 200d $494 — 200d above 50d
Institutional flow Accumulating
1,240 of 2,351 funds reported for Sep 30 · net +1.5M sh shares · +78 new
Insider flow Distributing
Net -$4.8M over 90 days · 50% sells
Short interest Rising
1.35% of shares out · ▲ +3.5% MoM · 2.9 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
2,351 holders — near 3-yr high, broad support
Squeeze score 50
elevated · 0–100
Fundamentals
Strong
Revenue growth +3%
Y/Y
EPS growth +7%
Y/Y
Free cash flow $5.1B
Valuation P/E 33.9
in line
Buyback $4.7B
remaining
Balance sheet $11.4B
net debt
Quant / Vol
risk profile
Very Low
Volatility 19%
annualized · 1-yr
Max drawdown −16%
past year
ATR 1.7%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Beat or met 0 of last 3
Latest guidance · from the 8-K filed Oct 29, 2026
the fourth quarter of 2026
Adjusted diluted earnings per share Non-GAAP $4.40 – $4.50
the full year 2026
Adjusted diluted earnings per share Non-GAAP Raised $17.82 – $17.92
Jul 31, 2026 $17.70 – $17.90 changed to Oct 29, 2026 $17.82 – $17.92
full year 2026
Full-year capital expenditures $5.5B – $6B
Previous outlook earlier release · from the Earnings Call filed Feb 5, 2026

Still-open targets the latest release did not restate under the same label.

EPS · full year 2026 $17.40 – $17.90
Prior guidance period ended · from the 8-K filed Jul 31, 2026
Adjusted diluted earnings per share · third quarter of 2026 $4.45 – $4.55
Guided vs delivered · last 3 settled
EPS full year 2021
guided $10.10 – $10.30
$7.33 Miss −28.1%
EPS first quarter
guided $2.20 – $2.25
$1.86 Miss −16.4%
EPS full year
guided $8.05 – $8.10
$4.71 Miss −41.7%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Strong Buy
0 · 3 · 4
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+6% Bullish
Price vs 50-day avg
+8% Bullish
RSI (14)
70 Neutral
MACD trend
Positive Bullish
52-week position
86% Bullish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross) No cross
50d $485 › 200d $494 — 200d above 50d
Institutional flow Accumulating
1,240 of 2,351 funds reported for Sep 30 · net +1.5M sh shares · +78 new
Insider flow Distributing
Net -$4.8M over 90 days · 50% sells
Short interest Rising
1.35% of shares out · ▲ +3.5% MoM · 2.9 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
2,351 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $389 Now $525 · 86% Range high $547
vs 200-day avg +6% vs 50-day avg +8%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Acquisitions/divestitures 1% third quarter of 2026 filing —
Adjusted depreciation and amortization non-GAAP 777M Quarter Ended September 30, 2026 filing —
GAAP → non-GAAP reconciliation
GAAP Reported depreciation and amortization $965M
-$188M Less: Purchase accounting impacts - Linde AG (c)
= Adjusted depreciation and amortization $777M
Adjusted effective tax rate non-GAAP 23.8% Quarter Ended September 30, 2026 filing —
Adjusted income from equity investments non-GAAP 80M Quarter Ended September 30, 2026 filing —
GAAP → non-GAAP reconciliation
GAAP Reported income from equity investments $61M
+$19M Add: Purchase accounting impacts - Linde AG (c)
+$0M Add: Cost reduction program and other charges
= Adjusted income from equity investments $80M
Adjusted net pension and OPEB cost (benefit), excluding service costs non-GAAP -53M Quarter Ended September 30, 2026 filing —
GAAP → non-GAAP reconciliation
GAAP Reported net pension and OPEB cost (benefit), excluding service cost -$49M
-$4M Add: Pension settlement charges
= Adjusted Net Pension and OPEB cost (benefit), excluding service costs -$53M
Adjusted noncontrolling interests non-GAAP -50M Quarter Ended September 30, 2026 filing —
GAAP → non-GAAP reconciliation
GAAP Reported noncontrolling interests -$48M
-$2M Add: Purchase accounting impacts - Linde AG (c)
= Adjusted noncontrolling interests -$50M
Adjusted other income (expense) - net non-GAAP 27M Quarter Ended September 30, 2026 filing —
GAAP → non-GAAP reconciliation
GAAP Reported other income (expense) - net $27M
+$0M Add: Purchase accounting impacts - Linde AG (c)
= Adjusted other income (expense) - net $27M
Approximate DollarValue of Shares thatMay Yet be PurchasedUnder the Program (2)(Millions) 4.68B Third Quarter 2026 filing —
AveragePrice PaidPer Share $491.05 Third Quarter 2026 filing —
Currency 1% third quarter of 2026 filing —
free cash flow non-GAAP $1.78B the third quarter —
Linde Engineering order intake $499M the third quarter —
third-party sale of equipment backlog $2.9B the third quarter —
Third-quarter operating cash flow $3.17B the third quarter —
Total Number of Shares Purchased (Thousands) 1.94M Third Quarter 2026 filing —
Total Numbers of Shares Purchased as Part of Publicly Announced Program (1) (Thousands) 1.94M Third Quarter 2026 filing —
Volume 2% third quarter of 2026 filing —
Adjusted EBITDA non-GAAP $3.57B Quarter Ended June 30, 2026 filing —
GAAP → non-GAAP reconciliation
GAAP Net Income - Linde plc 1.93B
+44M Add: Noncontrolling interests
-53M Add: Net pension and OPEB cost (benefit), excluding service cost
+61M Add: Interest expense
+610M Add: Income taxes
+963M Add: Depreciation and amortization
+0M Add: Cost reduction program and other charges
+19M Add: Purchase accounting impacts - Linde AG (c)
= Adjusted EBITDA 3.57B
EBITDA $3.55B second quarter 2026 filing —
Return on capital non-GAAP 23.5% second-quarter 2026 —
Sale of gas backlog $8.1B second-quarter 2026 —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Specialty Chemicals — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
LIN
Linde PLC
this stock
$234.84B +23.1% +3.0% 33.9 1.3%
AIQUF
L Air Liquide SA
$130.70B +11.6% — — 0.0%
ECL
Ecolab Inc.
$88.35B +20.0% +2.2% 41.5 1.7%
SHW
Sherwin Williams Co
$87.99B +12.2% +2.1% 33.5 2.7%
APD
Air Products & Chemicals, Inc.
$71.01B +29.1% -0.5% — 2.1%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
2,372
% held
87.1%
Reported
1,240 of 2,351
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
447
View
Short & Settlement
Short Interest Rising
Shares short
6.2M
Days to cover
2.9d
Change
+209.1K sh
View
Short Volume
Short vol %
51%
As of
Nov 4, 2026
Short Total
View
Fails to Deliver
FTD shares
1.5K
Value
$729.9K
As of
Sep 30, 2026
View
Off-Exchange
Off-exchange %
41.7%
Week of
Sep 28, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net selling
Net (90d)
-$4.8M
Buyers / Sellers
1 / 1
Buyers Sellers
View
Congressional Trades Sell
Member
Kevin Hern
Amount
$15.0K–$50.0K
Traded
Sep 17, 2026
View
Financials
Financials
Revenue (FY)
$34.0B
Net income (FY)
$6.9B
EPS diluted
$14.61
View
Buybacks
Authorized · 2 programs
$25.0B
Remaining
$4.7B
Spent Remaining
View
Filings
SEC Filings
Latest
8-K
Filed
Oct 29, 2026
This year
14

Linde plc reported third-quarter 2026 sales of $9.4 billion, up 9%, and adjusted EPS of $4.59, up 9%. Full-year adjusted EPS guidance is $17.82 - $17.92, up 8% to 9%, while operating cash flow reached $3.2 billion.

View
Proposed Sales
Value
$45.3M
Shares
86.8K
Filed
Nov 4, 2026
View
Earnings & Events
Webcasts
Last webcast
Oct 29, 2026
View
Investor Relations
Latest news
Linde Reports Third Quarter 2026…
Published
Oct 29, 2026
Upcoming events
3
View

Performance

5D 20D 120D MTD YTD
LIN +3.3% +8.4% +2.6% +2.0% +23.1%
SPY -0.7% -1.3% +2.5% +1.5% +12.5%
vs SPY +4.0% +9.8% +0.1% +0.6% +10.6%

Capital returns

Latest dividend
$1.60 / share · ex Sep 3, 2026
Declared · upcoming
$1.60 / share · ex Dec 3, 2026
Raised 6.7%
Paid (TTM)
$6.30 / share · 4 payouts
Dividend yield (TTM, derived)
1.20%
Full dividend history
Buyback programs · 2 active · as of Sep 30, 2026
Authorized (total)
$25.00B
Spent (derived)
$20.30B
Remaining
$4.70B
Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1707925 CUSIP G54950103 13F (30d) 1207 filings 1157 filers Visit website Investor relations